US 11439635
B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoholic fatty liver disease
granted A61KA61K31/427A61K31/4725
Quick answer
US patent 11439635 (B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoholic fatty liver disease) held by Northwestern University expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/427, A61K31/4725, A61K31/506, A61K9/0053